{"product_id":"phospho-vegf-receptor-2-y1175-recombinant-rabbit-mab-s-m0024-s0b60114","title":"Phospho-VEGF Receptor 2 (Y1175) Recombinant Rabbit mAb (S-M0024)","description":"\u003ch4\u003eProduct Specification\u003c\/h4\u003e\u003cdiv class=\"responsive-table product-detail-table details-table\"\u003e\n\u003cbr\u003e\u003ctable style=\"width: 100%; height: auto;\"\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eHost\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eRabbit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eAntigen\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003ePhospho-VEGF Receptor 2 (Y1175)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eSynonyms\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eVascular endothelial growth factor receptor 2; VEGFR-2; Fetal liver kinase 1 (FLK-1); Kinase insert domain receptor (KDR); Protein-tyrosine kinase receptor flk-1; CD309; FLK1; VEGFR2; KDR\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eLocation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eCell membrane, Endoplasmic reticulum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eAccession\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eP35968\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eClone Number\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eS-M0024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eAntibody Type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eRecombinant mAb\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eIsotype\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eIgG\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eApplication\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eWB\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eReactivity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eHu\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003ePositive Sample\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eA431 starve overnight, then treated with 100 ng\/ml hEGF for 5 minutes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003ePurification\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eProtein A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eConcentration\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e1.75 mg\/ml\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eConjugation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eUnconjugated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003ePhysical Appearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eLiquid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eStorage Buffer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\u003cp\u003ePBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eStability \u0026amp; Storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\u003cp\u003e12 months from date of receipt \/ reconstitution, -20 °C as supplied\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003c\/div\u003e\u003ch4\u003eDilution\u003c\/h4\u003e\u003cdiv class=\"responsive-table product-detail-table details-table\"\u003e\n\u003cbr\u003e\u003ctable style=\"width: 60%; height: auto;\"\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eapplication\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003edilution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003especies\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWB\u003c\/td\u003e\n\u003ctd\u003e1:1000-1:5000\u003c\/td\u003e\n\u003ctd\u003eHu\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003c\/div\u003e\u003ch4\u003eBackground\u003c\/h4\u003e\u003cdiv\u003e\u003cp\u003e\u003cspan style=\"color:#000000\"\u003ePhospho-VEGF Receptor 2 (Y1175) is the activated form of vascular endothelial growth factor receptor 2 (VEGFR2) phosphorylated at tyrosine residue 1175, and this event represents a core hallmark of VEGF signaling pathway activation. VEGFR2 is a receptor tyrosine kinase primarily expressed on vascular endothelial cells; upon binding to its ligand VEGF-A, the receptor undergoes dimerization and transphosphorylation, among which Y1175 is located within the intracellular kinase insert domain (KID) and is one of the earliest and most important autophosphorylation sites following receptor activation. Phosphorylation at this site recruits SH2 domain-containing adaptor proteins such as phospholipase \u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003eCγ\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003e (\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003ePLCγ\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003e), VARP, and \u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003eSck\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003e\/\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003eShcB\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003e, thereby initiating multiple downstream \u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003ekey\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003e signaling cascades. Among these, the PLCγ-Ca²⁺-\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003eeNOS\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003e pathway regulates vascular permeability and nitric oxide production, while the Ras-Raf-MEK-ERK pathway activated through adaptor proteins such as \u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003eShc\u003c\/span\u003e\u003cspan style=\"color:#000000\"\u003e primarily drives endothelial cell proliferation, migration, and survival. Therefore, Phospho-VEGFR2 (Y1175) not only serves as a reliable molecular marker for assessing VEGFR2 kinase activity but also represents a core node regulating angiogenesis, vascular remodeling, and vascular barrier function. In oncology, aberrant hyperphosphorylation at this site is frequently closely associated with tumor neovascularization, invasion, metastasis, and resistance to anti-VEGF targeted therapies, making the Y1175 site an important research and monitoring target for evaluating the efficacy of anti-angiogenic drugs and developing novel intervention strategies.\u003c\/span\u003e\u003c\/p\u003e\u003c\/div\u003e","brand":"Starter","offers":[{"title":"25μl","offer_id":43096308383819,"sku":"S0B60114-25μl","price":100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0590\/8375\/1499\/files\/a8183d38a69141798a47caa7ff92ad56.jpg?v=1788235284","url":"https:\/\/www.antbioinc.com\/products\/phospho-vegf-receptor-2-y1175-recombinant-rabbit-mab-s-m0024-s0b60114","provider":"AntBio","version":"1.0","type":"link"}